Polycystic ovary syndrome renamed to polyendocrine metabolic ovarian syndrome
The Story
According to a Guardian podcast episode, polycystic ovary syndrome (PCOS) has been renamed after more than a decade of global consultation. The condition, which affects as many as one in eight women, is caused by high levels of androgens and can lead to symptoms such as excess hair, weight gain, and irregular periods. The new name is polyendocrine metabolic ovarian syndrome (PMOS). The podcast features Guardian science correspondent Nicola Davis and Rachel, a campaigner from the charity Verity, discussing the reasons behind the change and what it could mean for patients.
Key Facts
- PCOS has been renamed to polyendocrine metabolic ovarian syndrome (PMOS) after more than a decade of global consultation.
- The condition affects as many as one in eight women.
- It is caused by high levels of androgens.
- Symptoms include excess hair, weight gain, and irregular periods.
- The podcast includes Guardian science correspondent Nicola Davis and Rachel, a campaigner from the charity Verity.
Conflicting Reports
No conflicting reports identified in the source article.
Still Unclear
No open questions identified in the source article.
Misconceptions
No widespread misconceptions addressed in the source article.
Key Figures
- Nicola Davis (Guardian science correspondent)
- Rachel (campaigner from the charity Verity)
Sources: The Guardian
